TrialJTCVS open2024

Safety of intranasal insulin administration in patients undergoing cardiovascular surgery: An open-label, nonrandomized, dose-escalation study.

Yosuke Nakadate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.